More on VTVT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-6.5% Growth)
- Ratings (7.9 Score)
- Holders

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

vTv Therapeutics (NQ:VTVT)
Delayed: 31.86 -1.43 (4.3%)
Prev. Close $33.29  
Open$33.00 
52 Wk High$7.70 
52 Wk Low$4.69 
Day High$33.00 
Day Low$31.85 
P/E N/A  
EPS$0.00 
Volume46,339 


Sep 2, 2026 08:00 AM vTv Therapeutics to Participate in September Investor Conferences
Aug 19, 2026 04:05 PM vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Aug 6, 2026 04:33 PM Form 10-Q vTv Therapeutics Inc. For: Jun 30
Aug 6, 2026 04:26 PM Form 8-K vTv Therapeutics Inc. For: Aug 06
Aug 6, 2026 08:17 AM vTv Therapeutics (VTVT) Misses Q2 EPS by 15c
Aug 6, 2026 08:00 AM vTv Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Jul 29, 2026 06:45 PM Form SCHEDULE 13G/A vTv Therapeutics Inc. Filed by: MILLENNIUM MANAGEMENT LLC
Jul 28, 2026 04:05 PM vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Jul 2, 2026 04:05 PM vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Jun 30, 2026 07:56 AM Rodman & Renshaw Starts vTv Therapeutics (VTVT) at Buy
View All Articles

Entities mentioned with VTVT

View All Entities